Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer-Reference-Cited by-同舟云学术

Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer

Published:2018-02 Issue: Volume:115 Page:447-457
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Ciamporcero Eric,Daga Martina,Pizzimenti Stefania,Roetto Antonella,Dianzani Chiara,Compagnone Alessandra,Palmieri Antonietta,Ullio Chiara,Cangemi Luigi,Pili Roberto,Barrera Giuseppina

Funder

University of Turin

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference51 articles.

1. Molecular aspects of cancer cell resistance to chemotherapy;Rebucci;Biochem. Pharmacol.,2013

2. ROS stress in cancer cells and therapeutic implications;Pelicano;Drug Resist. Updat.,2004

3. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?;Trachootham;Nat. Rev. Drug Discov.,2009

4. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution;Taguchi;Genes Cells,2011

5. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles;Itoh;Free Radic. Biol. Med.,2004

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of YAP translocation by myeloid Pten deficiency alleviates acute lung injury via inhibition of oxidative stress and inflammation;Free Radical Biology and Medicine;2024-09

2. Hippo signaling modulation and its biological implications in urological malignancies;Molecular Aspects of Medicine;2024-08

3. A role for YAP/FOXM1/Nrf2 axis in oxidative stress and apoptosis of cataract induced by UVB irradiation;The FASEB Journal;2024-07-24

4. Targeting Nrf2 signaling pathways in the role of bladder cancer: From signal network to targeted therapy;Biomedicine & Pharmacotherapy;2024-07

5. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1;Pharmaceutical Biology;2024-04-04